Drug intelligence / Profile preview

Pregabalin and Dexmedetomidine combination

Development stage
Unknown
Lead developer
Pfizer
Administration
Oral, Intravenous
01

Overview

The combination of pregabalin and dexmedetomidine is used primarily for pain management, particularly in perioperative settings. This combination leverages the complementary mechanisms of both drugs to provide enhanced pain relief while potentially reducing side effects compared to higher doses of either medication alone. ## Pharmacology **Pregabalin** is a GABA analog that binds to the alpha-2-delta subgroup of calcium channels, reducing excitatory neurotransmitter release and preventing hyperalgesia and central sensitization[9]. It's primarily indicated for neuropathic pain, fibromyalgia, and as an adjunctive therapy for partial-onset seizures[5]. **Dexmedetomidine** is a highly selective alpha-2 adrenergic receptor agonist with a receptor selectivity (α2/α1) of 1,620:1[8]. It provides sedation, anxiolysis, and analgesia without significant respiratory depression. Its mechanism of action includes: 1. Peripheral analgesic effects by inhibiting pain signal transmission through Aδ and C fibers 2. Central analgesic effects by depolarizing the blue plaque and descending noradrenergic pathway 3. Local analgesic effects by modulating hyperalgesia through α2 receptor stimulation[8] ## Clinical Applications The combination of pregabalin and dexmedetomidine has been studied for several clinical applications: 1. **Postoperative Pain Management**: Studies have evaluated this combination for pain relief after total knee or hip arthroplasty[1][4][7]. The combination might reduce pain intensity on the visual analog scale (VAS) and decrease the volume of patient-controlled analgesia (PCA) containing morphine[7]. 2. **Hemodynamic Response Attenuation**: Research has compared the efficacy of pregabalin, dexmedetomidine, and their combination for attenuating hemodynamic stress responses during procedures like laparoscopic cholecystectomy[2]. 3. **Delirium Prevention**: The combination has been investigated for preventing delirium in elderly patients after cardiac surgery[9]. 4. **Sedation During Procedures**: Studies have assessed the effect of pregabalin premedication in conjunction with dexmedetomidine on sedation during cataract surgery[10]. ## Comparative Efficacy Interestingly, some research suggests that dexmedetomidine alone may be more effective than either pregabalin alone or the combination of pregabalin and dexmedetomidine in attenuating hemodynamic response to laryngoscopy[2]. However, the combination group showed significantly higher sedation scores in the preoperative period, reduced requirement of propofol, longer time for extubation and to respond to verbal commands after reversal, and lower pain scores compared to pregabalin alone[2]. The therapeutic efficacy of dexmedetomidine can be increased when used in combination with pregabalin[5], suggesting a potential synergistic effect that could allow for lower doses of each medication while maintaining efficacy. This combination represents an important approach in multimodal analgesia, potentially offering improved pain management with fewer side effects compared to traditional opioid-based regimens.

Other names
pregabalin combined with intranasal dexmedetomidinepregabalin + dexmedetomidine-Beijing Tiantan Hospital-Fibromyalgia
02

Targets

ADRA2A (α2A)α2δ (Voltage-gated calcium channel alpha-2-delta subunit)

Beyond the preview

Go deeper on Pregabalin and Dexmedetomidine combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pregabalin and Dexmedetomidine combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call